Cargando…
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings
Despite mass drug administration programmes with praziquantel, the prevalence of schistosomiasis remains high. A vaccine is urgently needed to control transmission of this debilitating disease. As some promising schistosomiasis vaccine candidates are moving through pre-clinical and clinical testing,...
Autores principales: | Driciru, Emmanuella, Koopman, Jan Pieter R., Cose, Stephen, Siddiqui, Afzal A., Yazdanbakhsh, Maria, Elliott, Alison M., Roestenberg, Meta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970007/ https://www.ncbi.nlm.nih.gov/pubmed/33746974 http://dx.doi.org/10.3389/fimmu.2021.635985 |
Ejemplares similares
-
Risk assessment for the implementation of controlled human
Schistosoma mansoni infection trials in Uganda
por: Koopman, Jan Pieter, et al.
Publicado: (2019) -
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda
por: Egesa, Moses, et al.
Publicado: (2022) -
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
por: Abaasa, Andrew, et al.
Publicado: (2023) -
Early Induction of Human Regulatory Dermal Antigen Presenting Cells by Skin-Penetrating Schistosoma Mansoni Cercariae
por: Winkel, Béatrice M. F., et al.
Publicado: (2018) -
Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018)